Cargando…
Exploring the Therapeutic Potential of Apigenin in Obesity-Associated Fibrinolytic Dysfunction: Insights From an Animal Study
Introduction: Obesity (Obe) is a chronic metabolic disorder usually complicated by impaired fibrinolytic activity. Apigenin (Api) is one of the flavonoids that have anti-adiposity effects. This study aimed to explore the therapeutic potential of Api in high-fat diet (HFD)-induced obese rats. Methods...
Autores principales: | Qadi, Hasan H, Bendary, Mohamed A, Almaghrabi, Safa Y, Zaher, Mohammed Alameen F, Karami, Mohamed M, Alsehli, Ahmed M, Babateen, Omar, Arbaeen, Ahmad F, Burzangi, Abdulhadi S, Bazuhair, Mohammed A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370825/ https://www.ncbi.nlm.nih.gov/pubmed/37503477 http://dx.doi.org/10.7759/cureus.40943 |
Ejemplares similares
-
Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice
por: Alghamdi, Adel, et al.
Publicado: (2022) -
Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen
por: Bendary, Ahmed, et al.
Publicado: (2017) -
Urolithin A’s Antioxidative, Anti-Inflammatory, and Antiapoptotic Activities Mitigate Doxorubicin-Induced Liver Injury in Wistar Rats
por: Karim, Shahid, et al.
Publicado: (2023) -
Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators
por: Al-Shareef, Ebtihal, et al.
Publicado: (2023) -
A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients
por: Narula, Naureen, et al.
Publicado: (2021)